In a study utilizing ovarian cancer cell lines, Jia et al. observed decreased cancer cell proliferation and motility after the addition of FAK inhibitors [52], suggesting that FAK may be involved in tumor growth and migration promotion. The gene discussed is PTK2; the disease is cancer.